Martek Says “Momentum” For DHA Ingredient Drives Sales Growth
This article was originally published in The Tan Sheet
Martek Biosciences' revenues grew 12 percent to $70.3 million in its fiscal 2007 first quarter from the prior-year quarter as 11 products containing its DHA ingredient were launched, the Columbia, Md.-based firm said March 7
You may also be interested in...
Martek Biosciences continues to push its growth with a new restructuring plan that should make it leaner and meaner, according to an Oct. 26 release
US Ninth Circuit affirms a district court’s summary judgment in favor of Target and manufacturer of Up & Up brand biotin supplement it sells. Indian manufacturer targeted in putative class-action in New York prompted FDA’s 2016 creation of import alert category for Ayurvedic supplements.
In its “robust, holistic hub” online, firms in the VMS product supply chain can determine their needs, “by product, solution or delivery formats,” and use a “comprehensive and unique portfolio” to “turn natural sources into shelf-ready products.”